Prescription Stimulants: From Cognitive Enhancement to Misuse.
ADHD
Attention-deficit/hyperactivity disorder
College students
Nonmedical use of prescription stimulants
Stimulant misuse
Transitional age youth
Journal
Pediatric clinics of North America
ISSN: 1557-8240
Titre abrégé: Pediatr Clin North Am
Pays: United States
ID NLM: 0401126
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
entrez:
5
11
2019
pubmed:
5
11
2019
medline:
3
3
2020
Statut:
ppublish
Résumé
The nonmedical use of prescription stimulants has become increasingly pervasive among transitional age youth (TAY), aged 16 years to 26 years. Although therapeutically administered stimulants are regarded as safe and effective in TAY with attention-deficit/hyperactivity syndrome (ADHD), stimulant misuse is of concern due to prevalence, behavioral health and substance use correlates, and negative short-term and long-term outcomes. Although academic motivations primarily drive misuse, it is unclear whether prescription ADHD stimulants enhance cognition. Providers are advised to exercise precautions when prescribing ADHD medications, enhance surveillance for misuse, and screen those with misuse for ADHD and other psychopathology, executive dysfunction, and substance use disorders.
Identifiants
pubmed: 31679601
pii: S0031-3955(19)30114-2
doi: 10.1016/j.pcl.2019.08.006
pii:
doi:
Substances chimiques
Central Nervous System Stimulants
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1109-1120Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.